Epidemiology and outcome of infections due to Aspergillus terreus: 10-Year single centre experience

British Journal of Haematology

Volumn 131, Issue 2, 2005, Pages 201-207

  Lass Flörl, Cornelia ^a   Griff, Katharina ^a   Mayr, Astrid ^a   Petzer, Andreas ^a   Gastl, Günter ^a   Bonatti, Hugo ^a   Freund, Martin ^a   Kropshofer, Gabriele ^a   Dierich, Manfred P ^a   Nachbaur, David ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Aspergillus terreus; Environment; Epidemiology; Infections

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; ITRACONAZOLE; VORICONAZOLE; CYCLOPEPTIDE; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS TERREUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENDEMIC DISEASE; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; MALE; MOLECULAR TYPING; NEUTROPENIA; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME; ANTIBIOTIC RESISTANCE; ASPERGILLUS; AUSTRIA; BLOOD DISEASE; FUNGAL GENE; GENETICS; LUNG MYCOSIS; MICROBIOLOGY; MIDDLE AGED; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PREVALENCE; RETROSPECTIVE STUDY;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; ASPERGILLOSIS; ASPERGILLUS; AUSTRIA; DRUG RESISTANCE, FUNGAL; FEMALE; GENES, FUNGAL; HEMATOLOGIC NEOPLASMS; HUMANS; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION; PEPTIDES, CYCLIC; PREVALENCE; PYRIMIDINES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZOLES;

EID: 28444468369     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2005.05763.x     Document Type: Article

References (35)

1. Anaissie E. ( 1992) Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clinical Infectious Diseases, 14 ( Suppl. 1 43 53.
2. Anaissie E. Bodey G.P. ( 1989) Nosocomial fungal infections. Old problems and new challenges. Infectious Disease Clinics of North America, 3, 867 882.
3. Anaissie E. Costa S.F. ( 2001) Nosocomial aspergillosis is waterborn. Clinical Infectious Diseases, 33, 1546 1548.
4. Ascioglu S. Rex J. De Pauw B. Bennett J.E. Bille J. Crokaert F. Denning D.W. Donnelly J.P. Edwards J. Erjavec Z. Fiere D. Lortholary O. Maertens J. Meis J.F. Patterson T.F. Ritter J. Selleslag D. Shah P.M. Stevens D.A. Walsh T. on behalf of the Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Mycoses Study Group of the National Institute of Allergy and Infectious Diseases ( 2002) Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clinical Infectious Diseases, 34, 7 14.
5. Baddley J.W. Stroud T.A. Salzman D. Pappas P. ( 2001) Invasive mold infections in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases, 32, 319 324.
6. Baddley J.W. Pappas P. Smith A.C. Moser S. ( 2003) Epidemiology of Aspergillus terreus at a University Hospital. Journal of Clinical Microbiology, 41, 5525 5529.
7. Birch M. Denning D.W. ( 1999) Molecular typing of Aspergillus terreus by random amplification of polymorphic DNA. European Journal of Clinical Microbiology and Infectious Diseases, 18, 838 841.
8. Bodey G.P. Vartivarian S. ( 1989) Aspergillosis. European Journal of Clinical Microbiology and Infectious Diseases, 8, 413 437.
9. Bodey G.P. Bueltmann B. Duguid W. Gibbs D. Hanak H. Hotchi M. Mall G. Martino P. Meunier F. Milliken S. ( 1992) Fungal infections in cancer patients: an International Autopsy Study. European Journal of Clinical Microbiology and Infectious Diseases, 11, 99 109.
10. Denning D.W. ( 1991) Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host. Journal of Antimicrobial Chemotherapy, 28 ( Suppl. B 1 16.
11. Denning D.W. ( 1994) Invasive aspergillosis in immunocompromised patients. Current Opinion of Infectious Diseases, 7, 456 462.
12. Denning D.W. ( 1998) Invasive aspergillosis in AIDS-an overview. Journal de Mycologie Medicale, 2, 34 41.
13. Einsele H. Hebart H. Roller G. Löffler J. Rothenhöfer I. Müller C. Bowden R. Burik J.A. Engelhard D. Kanz L. Schumacher U. ( 1997) Detection and identification of fungal pathogens in blood by using molecular probes. Journal of clinical Microbiology, 35, 1353 1360.
14. Espinel-Ingroff A. ( 2003) Evaluation of broth microdilution testing parameters and agar diffusion Etest procedure for testing susceptibilities of Aspergillus spp. to caspofungin acetate (MK-0991). Journal of Clinical Microbiology, 41, 403 409.
15. Flynn P. Williams B. Hetherington S. Williams B. Giannini M. Pearson T. ( 1993) Aspergillus terreus during hospital renovation. Infection Control and Hospital Epidemiology, 14, 363 365.
16. Hachem R. Kontoyiannis D. Boktour M. Afif C. Cooksley C. Bodey G.P. Chatzinikolaou I. Perego C. Kantarjian H. Raad I. ( 2004) Aspergillus terreus an emerging amphotericin B -resistant opportunistic mold in patients with hematologic malignancies. Cancer, 101, 1594 1600.
17. Hara K.S. Ryu J.H. Lie J.T. Roberts G.D. ( 1989) Disseminated Aspergillus terreus infection in immunocompromised hosts. Mayo Clinic Proceedings, 64, 770 775.
18. Herbrecht R. Denning D. Patterson T.F. Bennett D. Greene E. Oestmann J.-W. Kern W. Marr A.K. Ribaud P. Lortholary O. Sylvester R. Wigard J. Rubin R. Stark P. Durand C. Caillot D. Eckhard T. Chandrasekar P.H. Hodges M. Schlamm H. Troke P. Ben de Pauw P. ( 2002) Voriconazole versus amphotericin B for primary therapy of Invasive aspergillosis. The New England Journal of Medicine, 347, 408 415.
19. Iwen P.C. Rupp M.E. Langnas A.N. Reed E.C. Hinrichs S.H. ( 1998) Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-years experience and review of the literature. Clinical Infectious Diseases, 26, 1092 1097.
20. Krasinski K. Holzman R. Hanna B. Greco A. Graff M. Bhogal M. ( 1985) Nosocomial fungal infection during hospital renovation. Infection and Control, 6, 278 282.
21. Lass-Flörl C. Rath P.M. Niederwieser D. Kofler G. Würzner R. Kreczy A. Dierich M.P. ( 2000) Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. Journal of Hospital Infection, 46, 31 35.
22. Lass-Flörl C. Aigner J. Eberhard G. Petzer A. Nachbaur D. Gastl G. ( 2001) Screening for Aspergillus spp. using polymerase chain reaction of whole blood samples from patients with haematological malignancies. British Journal of Haematology, 113, 180 184.
23. Lass-Flörl C. Gunsilius E. Gastl G. Englisch M. Koch G. Ulmer H. Dierich M.P. Petzer A. ( 2003) Fungal colonization in neutropenic patients: a randomized study comparing itraconazole solution and amphotericin B solution. Annual Hematology, 82, 565 569.
24. Marr A.K. Carter R.B.M. Martin P. Corey L. ( 2002) Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood, 100, 4358 4366.
25. Martino P. Raccah R. Gentile G. Venditti M. Girmenia C. Mandelli F. ( 1989) Aspergillus colonization of the nose and pulmonary aspergillosis in neutropenic patients: a retrospective study. Haematologica, 74, 263 265.
26. McNeil M.M. Nash S.L. Hajjeh R.A. Phelan M.A. Conn L.A. Warnock D.W. ( 2001) Trends in mortality due to invasive mycotic diseases in the united states, 1980-1997. Clinical Infectious Diseases, 33, 641 647.
27. Oren I. Haddad N. Finkelstein R. Rowe J. ( 2001) Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. American Journal of Hematology, 66, 257 262.
28. Perfect J. Cox G. Lee J.Y. Kauffman C.A. Repentigny L. Chapman S.W. Morrison V.A. Pappas P. Hiemenz J.W. Stevens D. Mycoses Study Group ( 2001) The impact of culture isolation of Aspergillus species: a hospital based survey of aspergillosis. Clinical Infectious Diseases, 33, 1824 1833.
29. Ribaud P. Chastang C. Latge P. Baffroy-Lafitte L. Parquet N. Devergie A. Esperou H. Selimi F. Rocha V. Derouin F. Socie G. Gluckman E. ( 1999) Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clinical Infectious Diseases, 28, 322 330.
30. Ruhnke M. Böhme A. Buchheidt D. Donhuijsen K. Einsele H. Enzensberger R. Glasmacher A. Gümbel H. Heussel C.P. Karthaus M. Lambrecht E. Südhoff T. Szelènyi H. ( 2003) Diagnosis of invasive fungal infections in hematology and oncology. Annual Hematology, 82, 141 148.
31. Steinbach W. Benjamin D. Kontoyiannis D. Perfect J. Lutsar I. Marr K. Lionakis M. Torres H. Jafri H. Walsh T. ( 2004a) Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases. Clinical Infectious Diseases, 39, 192 198.
32. Steinbach W. Perfect J. Schell W. Walsh T. Benjamin D. ( 2004b) In vitro analyses, animal models, and 60 clinical isolates of invasive Aspergillus terreus infection. Antimicrobial Agents and Chemotherapy, 48, 3217 3225.
33. Sutton D.A. Sanche S.E. Revankar S.G. Fothergrill A. Rinaldi M. ( 1999) In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. Journal of Clinical Microbiology, 37, 2343 2345.
34. Walsh T.J. Dixon D.M. ( 1989) Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment. European Journal Epidemiology, 5, 131 142.
35. Walsh T. Petraitis V. Petraitiene R. Field-Ridely A. Sutton D.A. Ghannoum M. Sein T. Schaufele R. Peter J. Bacher J. Casler H. Armstrong D. Espinel-Ingroff A. Rinaldi M. Lyman C.A. ( 2003) Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B. The Journal of Infectious Diseases, 188, 305 319.